JOTEC joins the CryoLife family

12-Oct-2017 - On October 10, 2017, the Hechingen-based medical device company JOTEC and the US company CryoLife signed an agreement under which CryoLife will acquire JOTEC for 225 million US Dollars, consisting of 75 percent in cash and up to 25 percent in Candy common stock issued to JOTEC’S shareholders. The ...

CryoLife Announces Retirement of Founder and Executive Chairman Steven G. Anderson

14-Apr-2015 - CryoLife, Inc. announced that Steven G. Anderson, 76, Executive Chairman of the Board of Directors, has decided to retire effective immediately. As a result of his retirement, he will step down from all positions with the company and its subsidiaries, including as a member of the Board of ...

Pat Mackin Joins CryoLife Board of Directors

24-Oct-2014 - CryoLife, Inc. announced that James Patrick (Pat) Mackin, President and Chief Executive Officer, has been elected to the Company's Board of Directors, effective October 21, 2014.Mr. Mackin joined CryoLife in September 2014 from Medtronic, Inc., where he most recently served as President of ...

CryoLife announces expansion in Asia Pacific Markets

21-Feb-2014 - CryoLife, Inc. announced the establishment of CryoLife Asia Pacific Pte. Ltd., a wholly-owned subsidiary of CryoLife, Inc., to expand the Company's presence in the rapidly growing Asia Pacific medical device market.To support the new subsidiary, CryoLife will relocate Mr. Rich Gridley, vice ...

CryoLife receives $15.4 million payment

28-Oct-2013 - CryoLife, Inc. announced that it received in the fourth quarter of 2013 a payment of $15.4 million for its 2,379,554 shares of Medafor, Inc. common stock associated with the closing of the acquisition of Medafor, Inc.

CryoLife to Acquire Hemosphere

18-May-2012 - CryoLife, Inc. announced that it has signed a definitive agreement to acquire Hemosphere, Inc., a privately-held medical device company that has developed and markets the HeRO (Hemodialysis Reliable Outflow) Graft. The HeRO Graft is a proprietary graft-based solution for end-stage renal disease ...

CryoLife Enhances Management Team with Promotions

New Vice Presidents Provide Added Focus to Key Growth Drivers

06-Jan-2012 - CryoLife, Inc. announced that it has promoted David C. Gale, Ph.D., to the position of Vice President, Research and Development; and David P. Lang to the newly created position of Vice President, Market Development Surgical Adhesives and Starch Medical Relations. Dr. Gale will report to Steven ...

CryoLife Announces Completion of Acquisition of Cardiogenesis

18-May-2011 - CryoLife, Inc. announced that it has successfully completed its acquisition of Cardiogenesis Corporation.The acquisition of Cardiogenesis adds to the company's portfolio a surgical product used in the treatment of diffuse coronary artery disease and severe angina. Cardiogenesis had sales of ...

CryoLife Signs Definitive Agreement to Acquire Cardiogenesis

31-Mar-2011 - CryoLife, Inc. and Cardiogenesis Corporation announced that the boards of directors of both companies have approved a definitive agreement under which CryoLife will acquire all of the outstanding shares of Cardiogenesis for $0.457 per share. The all-cash transaction values Cardiogenesis at ...

David P. Lang Appointed Vice President of CryoLife International, Inc.

06-Oct-2010 - CryoLife, Inc. announced that it has appointed David P. Lang as vice president of market development for CryoLife International Inc. In this newly created position, Mr. Lang will have responsibility for coordinating and developing the international marketing and distribution strategies for ...